Neuroscientific Biopharmaceuticals Ltd has released a press release.
Additional US Patent granted
Filed with ASX ·
6ix hasn’t read this filing yet.
Neuroscientific Biopharmaceuticals Ltd. on 6ix
Earlier from Neuroscientific Biopharmaceuticals
- CVN Model Indicates Neuroprotective Properties of EmtinB
- NSB - Company Update
- AGM Address
- EmtinB Can Become a Revolutionary Treatment for Glaucoma
- NSB Receives R&D Advanced Overseas Finding
Later from Neuroscientific Biopharmaceuticals
- Positive Results in Glaucoma Pig Model
- Positive Results in MS Study
- Final Report received for Glaucoma Study
- EmtinB Positive Results in MS
- Full Report from Multiple Sclerosis Study
Follow Neuroscientific Biopharmaceuticals into a list and get an email when it puts out news.
Follow Neuroscientific Biopharmaceuticals